Subsequently, we also investigated their association with amyloid/tau/neurodegeneration (A/T/N) biomarkers and cognitive function, aiming to contribute to the identification of potential blood-based molecular biomarkers for AD. This evidence concerns the gene MAPT and Alzheimer disease.